Tag Archives: BIO 2014 Health

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

Mary Canady

BIO 2014′s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this Evolution?” discussed progress and challenges facing researchers and the collaborative efforts between the Food and Drug Administration (FDA) and patient advocacy groups to help them find a cure. The discussion centered on recent FDA Draft Guidance for Early Stage Alzheimer’s Disease Drug Development which allows for an accelerated approval Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Exchange Plans are Helping Patients, But Challenges Remain

Session

After describing many of the benefits the Exchanges have brought to patients—including access to both coverage and federal subsidies—the moderator for the 2014 BIO International Convention breakout session, Impact of Exchanges for Patients, tasked panelists representing a diverse group of stakeholders to describe the challenges that remain for patients enrolled in Exchange plans. These challenges fell into four main categories, including: formulary depth, patient out-of-pocket costs, transparency, and provider networks. In terms of formulary depth, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Access to Big Data

Emerging-Companies115x76

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the explosion of information about cellular activities and disease pathways happening today. With this explosion, the challenge for scientific database producers is to curate and process the published literature, small molecules, proteins, sequences and numeric data in ways Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Seeing is Believing

brain-scan

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure of new drug programs is a major source of concern, with failure rates ranging from 75 percent in anti-infectives to 92 percent in CNS according to DiMasi’s 2010 study (Clin. Pharmacol. Ther. 87, 272-277). Molecular imaging – both Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) can help improve these dismal statistics. Given the immense costs involved in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

A Better Way to Make Unnatural Amino Acids Discovered by Yu

Make Unnatural Amino Acids

Certain amino acids that are not found in nature are highly sought after by pharmaceutical manufacturers. These “unnatural” amino acids have traditionally been very difficult to synthesize, so a new and improved technique for doing so is attracting a lot of attention. Amino acids are among the most basic components of living things. Long chains of them, translated from DNA, fold up to become proteins, some smaller groupings of amino acids form hormones, and a Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,